Target
Kallikrein-14
Ligand
BDBM33453
Substrate
n/a
Meas. Tech.
ChEMBL_973067 (CHEMBL2412648)
IC50
3430±n/a nM
Citation
 Tan, XFurio, LReboud-Ravaux, MVilloutreix, BOHovnanian, AEl Amri, C 1,2,4-Triazole derivatives as transient inactivators of kallikreins involved in skin diseases. Bioorg Med Chem Lett 23:4547-51 (2013) [PubMed]  Article 
Target
Name:
Kallikrein-14
Synonyms:
KLK-L6 | KLK14 | KLK14_HUMAN | KLKL6 | Kallikrein 14 | Kallikrein-14 | Kallikrein-like protein 6 | hK14
Type:
PROTEIN
Mol. Mass.:
29136.99
Organism:
Homo sapiens (Human)
Description:
ChEMBL_1282452
Residue:
267
Sequence:
MSLRVLGSGTWPSAPKMFLLLTALQVLAIAMTQSQEDENKIIGGHTCTRSSQPWQAALLAGPRRRFLCGGALLSGQWVITAAHCGRPILQVALGKHNLRRWEATQQVLRVVRQVTHPNYNSRTHDNDLMLLQLQQPARIGRAVRPIEVTQACASPGTSCRVSGWGTISSPIARYPASLQCVNINISPDEVCQKAYPRTITPGMVCAGVPQGGKDSCQGDSGGPLVCRGQLQGLVSWGMERCALPGYPGVYTNLCKYRSWIEETMRDK
  
Inhibitor
Name:
BDBM33453
Synonyms:
(3-Amino-[1,2,4]triazol-4-yl)-(4-methoxy-phenyl)-methanone | (3-amino-1,2,4-triazol-4-yl)-(4-methoxyphenyl)methanone | (3-azanyl-1,2,4-triazol-4-yl)-(4-methoxyphenyl)methanone | MLS000528783 | SMR000121258 | cid_2938648
Type:
Small organic molecule
Emp. Form.:
C10H10N4O2
Mol. Mass.:
218.212
SMILES:
COc1ccc(cc1)C(=O)n1cnnc1N
Structure:
Search PDB for entries with ligand similarity: